Risk factors for development of diabetic nephropathy: A review

Nephrology Dialysis Transplantation

Volumn 12, Issue SUPPL. 2, 1997, Pages 24-26

  Strojek, Krzysztof ^a   Grzeszczak, Wladyslaw ^a   Ritz, Eberhard ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

ACE gene polymorphism; Albuminuria; Diabetic nephropathy; Hypertension; NIDDM

Indexed keywords

ARTICLE; CEREBROVASCULAR ACCIDENT; DIABETIC NEPHROPATHY; GENETIC PREDISPOSITION; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR;

ALBUMINURIA; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 0030794039     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Nelson RG, Knowler WC, Bennet PH: Natural history of diabetic nephropathy in non-insulin-dependent diabetes mellitus. J Diabet Compilc 1991; 5: 76-78
2. Hasslacher C, Ritz E, Wahl P, Michael C: Similar risks of nephropathy in patients with type I and type II diabetes. Nephrol Dial Transplant 1989; 4: 859-863
3. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320: 1161-1165
4. Pettit DJ, Saad MF, Bennet PH, Nelson RG, Knowler WC. Familial predisposition to renal disease in two generation of Pima Indians with type 2 non-insulin-dependent) diabetes mellitus. Diabetologia 1990; 33: 438-443
5. Earle K, Walker J, Hill C, Viberti GC. Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1992; 326: 673-677
6. Keller CK, Bergis KH, Fliser D, Ritz E. Renal findings in patients with short term type 2 diabetes. J Am Soc Nephrol (in press)
7. Ritz E, Stefanski A. Diabetic nephropathy in type II diabetes. Am J Kidney Dis 1996; 27: 167-194
8. Marre M, Bernadet P, Gallois Y, Savagner F, Tham-Tham G, Hallab M, Cambien F, Passa P, Alhenc-Gelas F. Relationship between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994; 43: 384-388
9. Schmidt S, Schone N, Ritz E and the Diabetic Nephropathy Study Group. Association of ACE gene polymorphism and diabetic nephroapthy? Kidney Int 1995; 47: 1176-1181
10. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving H-H. Lack of relationship between an Insertion/Deletion polymorphism in the angiotensin I converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995; 44: 489-494
11. Schmidt S, Stier E, Hartung R, Stein G, Bahnisch J, Woodroffe AJ, Clarkson AR, Ponticelli C, Campese M, Mayer G, Ganten D, Ritz E. No association of converting enzyme insertion/ deletion polymorphism with immunoglobulin A glomerulonephritis. Am J Kidney Dis 1995; 5: 727-737
12. Harden PN, Geddes C, Rowe PA, Mclllroy JH, Boulton-Jones M, Rodger RSC, Junor BJR, Briggs JD, Connell JMC, Jardine AG. Polymorphism in the angiotensin-converting enzyme gene and progression of IgA nephropathy. Lancet 1995; 345: 1540-1542
13. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, Nagasawa R, Kawaguchi Y, Kubo H, Ichikawa I, Sakai O. Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995; 96: 2162-2169
14. Jacobsen P, Tarnow L, Rossing P, Cambien F, Leclerf L, Poirer O, Parving HH: The insertion/deletion (I/D) polymorphism in the angiotensin I convering enzyme (ACE) gene predicts the progression of diabetic nephropathy during ACE inhibition in insulin-dependent diabetic (IDDM) patients. J Am Soc Nephrol 1995; 6: 450
15. Dudley CRK, Keavney B, Stratton I, Turner R, Ratcliffe PJ. UK Prospective Diabetes Study XV: Relationship of reninangiotensin gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 1995; 48: 1907-1911
16. Schmidt S, Strojek K, Grzeszczak W, Bergis K, Ritz E. Excess of DD-homozygotes in hemodialysed patients with type II diabetes. Nephrol Dial Transplant 1997; 12: 427-429
17. Fujisawa T, Ikegami H, Shen G-W, Yamamoto E, Nakagawa Y, Hamada Y, Ueda H, Rakukgi H, Higaki J, Ohishi M, Fujii K, Fukuda M, Ogihara T: Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995; 18: 983-985
18. Barzilay J, Warram JH, Bak M, Laffel LM, Canessa M, Krolewski AS. Predisposition to hypertension: Risk factor for nephropathy and hypertension in IDDM. Kidney Int 1992; 41: 723-730
19. Elving LD, Wetzels JFM, de Nobel E, Berden JHM. Erythrocyte sodium-liothium countertransport is not different in type I (insulin-dependent) diabetic patients with and without diabetic nephropathy. Diabetologia 1991; 34: 126-128
20. Mangili R, Bending JJ, Scott G, Li LK, Gupta A, Viberti GC. Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1988; 318: 146-150
21. Jensen JS, Mathiesen ER, Norgaard K, Hommel E, Borch-Johnsen K, Funder J, Brahm J, Parving HH, Deckert T. Increased blood pressure and eryhtrocyte sodium-lithium countertransport activity are not inherited in diabetic nephropathy. Diabetologia 1990; 33: 619-624
22. Pietruck F, Spleiter S, Sell A, Daul A, Philipp T, Derwahl M, Schatz H, Siffert W. Enhanced G protein activation and susceptibility to nephropathy in insulin-dependent diabetes mellitus (IDDM). Kongress Gesellschaft Nephrologie, Berlin 1996. Nieren- und Hochdruckkrankheiten 1996; 25, 444
23. Pugh JA, Medina R, Ramirez M. Comparison of the course to end-stage renal disease of type I insulin-dependent) and type 2 (non insulin-dependent) diabetic nephropathy. Diabetologia 1993; 36: 1094-1098
24. Nelson RG, Pettitt DJ, Baird HR, Charles MA, Liu QZ, Bennett PH, Knowler WC. Prediabetic blood pressure predicts urinary albumin secretion after the onset of type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1993; 36: 998-1001
25. Strojek K, Grzeszczak W, Morawin E, Adamski M, Lacka B, Rudzki H, Ritz E. Clinical manifestation of hereditary predisposition to type II diabetes and nephropathy. Nephrol Dial Transplant 1966; 11, 119
26. Schmid M, Meyer S, Wegner R, Ritz E. Increased genetic risk of hypertension in glomerulonephritis? Hypertension 1990; 8: 573-577
27. Gall MA, Nielsen FS, Shidt UM, Parving HH. The course of kidney function in type II (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 1993; 36: 1071-1078
28. Stefanski A, Schmidt KG, Waldherr R, Ritz E. Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis. Kidney Int 1996; 50: 1321-1326
29. Grünfeld B, Perelstein E, Simsolo R, Gimenez M, Romero JC. Renal functional reserve and microalbuminuria in offspring of hypertensive parents. Hypertension 1990; 15: 257-261
30. Gruden G, Cavallo-Perin P, Olivetti C, Repetti E, Sivieri R, Bruno A, Pagano G. Albumin excretion rate levels in non-diabetic offspring of NIDDM patients with and without nephropathy. Diabetologia 1995; 38: 1218-1222